ARCA biopharma Announces Additions to GENETIC-AF Leadership Team

Published: Jul 22, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has expanded the Company’s clinical trial leadership team with three new hires in clinical development and quality assurance: vice president – clinical development, senior director quality, and senior clinical program manager.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news